New anticoagulant drugs: a critical perspective
Haas, S.
Current Hematology Reports 4(5): 335-338
2005
ISSN/ISBN: 1541-0714 PMID: 16131432 Document Number: 587701
Document emailed within 1 workday
Related Documents
Patjanasoontorn, B. 2014: A critical look at critical care medicine in thailand critical care services and critical care workforce: the current situation and a future perspective Journal of the Medical Association of Thailand 97(Suppl 1): S121-S126Fürst, R.; Vollmar, A.M. 2013: A new perspective on old drugs: non-mitotic actions of tubulin-binding drugs play a major role in cancer treatment Die Pharmazie 68(7): 478-483
Payrow Shabani, O.A. 2007: Cosmopolitan justice and immigration : A critical theory perspective : Cosmopolitanism: Between past and future - Justice cosmopolite et immigration : Une perspective de la théorie critique : Cosmopolitisme : Entre passé et avenir European Journal of Social Theory 10(1): 87-98
Wynn, R.L. 2012: New antiplatelet and anticoagulant drugs General Dentistry 60(1): 8-11
Bourde, C. 1970: Use and misuse of anticoagulant drugs in phlebitis Marseille Medical 107(12): 1009-1011
Yamamoto, K. 2010: Anticoagulant or antiplatelet drugs and anesthesia Masui. Japanese Journal of Anesthesiology 59(9): 1160-1165
Biron, C.; Licznar, P.; Hansel, S.; Schved, J.F. 1999: Oral anticoagulant drugs: do not cut tablets in quarters Thrombosis and Haemostasis 82(3): 1201
Rakower, S.R.; Worth, M.H. 1973: Autotransfusion: perspective and critical problems Journal of Trauma 13(6): 573-574
Ammar, H.O.; Ghorab, M.; el-Nahhas, S.A.; Makram, T.S. 1997: Improvement of the biological performance of oral anticoagulant drugs. 2. Dicumarol Die Pharmazie 52(9): 727-728
Sawyer, P.N.; Stanczewski, B.; Pomerance, A.; Stoner, G.; Srinivasan, S. 1973: Utility of anticoagulant drugs in vascular thrombosis: electron microscopic and biophysical study Surgery 74(2): 263-275
Murgatroyd, F.D.; Leenhardt, A. 2000: Non-pharmacological treatments for atrial fibrillation. a critical perspective on the status quo Archives des Maladies du Coeur et des Vaisseaux 93(Special Issue 3): 7-16
Coombs, M. 1999: The challenge facing critical care nurses in the UK: a personal perspective Nursing in Critical Care 4(2): 81-84
Philipson, I. 1984: The Repression of History and Gender: a Critical Perspective on the Feminist Sexuality Debate Signs: Journal of Women in Culture and Society 10(1): 113-118
Morrow, B.M.; Argent, A.C.; Kling, S. 2015: Informed consent in paediatric critical care research--a South African perspective Bmc Medical Ethics 16: 62
Lee, J.-L.; Chen, W.-Y.; Hung, C.-T.; Hsu, M.-Y. 2011: Critical research issues in nursing policy and management: a healthcare system perspective Hu Li Za Zhi Journal of Nursing 58(3): 27-32
Chakraborty, A. 1990: Psychotropic drugs in a new perspective Journal of the Indian Medical Association 88(12): 333-334
Vrhovac, B.; Vrhovac, R. 1991: Critical review of drugs in 1990 Lijecnicki Vjesnik 113(1-2): 1-9
Gibbs, J.N.; Mazan, K.D. 2000: Compounding OTC Drugs: A Legal Perspective International Journal of Pharmaceutical Compounding 4(3): 180-181
2002: "Critical dose" drugs. Aut-idem could cause problems here MMWFortschrittederMedizin 144(3-4): 63
Byshevskiĭ, A.S.; Sokolovskiĭ, S.R. 1982: Potentiation of the anticoagulant effects of a phosphatidylserine-containing anticoagulant and heparin Voprosy Meditsinskoi Khimii 28(2): 30-34